Perspective Therapeutics CATX
NYSE CATX
$3.30 +0.09 (+2.80%)
At close: Aug 21, 2026 · 4:00 PM EDT

Perspective Therapeutics (CATX) Amortizatization of Intangibles (2010 - 2024)

Perspective Therapeutics (CATX) posted Amortizatization of Intangibles of $14000.0 for Q4 2023, up 55.56% sequentially from $9000.0 in Q3 2023, and down 17.65% YoY from $17000.0 in Q4 2022.

Perspective Therapeutics (CATX) Amortizatization of Intangibles (2010 - 2024) Analysis & Trends

Perspective Therapeutics has reported Amortizatization of Intangibles for 14 years, with the latest figure at $14000.0 in Q4 2023.

  • Quarterly Amortizatization of Intangibles fell 17.65% year-over-year to $14000.0 in Q4 2023, while the trailing twelve-month figure through Sep 2024 was $14000.0 (down 67.44% YoY) and the FY2023 annual result came in at $40000.0, up 21.21% from the prior year.
  • Amortizatization of Intangibles grew to $14000.0 in Q4 2023 per CATX's latest filing, from $9000.0 in the prior quarter.
  • Over five years, Amortizatization of Intangibles peaked at $25000.0 in Q3 2022 and troughed at -$9000.0 in Q4 2021.
  • A 5-year average of $10736.8 and a median of $10000.0 in 2020 frame the typical range for Amortizatization of Intangibles.
  • The sharpest annual moves came in 2021 and 2022: Amortizatization of Intangibles sank 250.0% in 2021, then soared 288.89% in 2022.
  • Over 5 years, Amortizatization of Intangibles stood at $13000.0 in 2019, then tumbled by 53.85% to $6000.0 in 2020, then tumbled by 250.0% to -$9000.0 in 2021, then jumped by 288.89% to $17000.0 in 2022, then retreated by 17.65% to $14000.0 in 2023.
  • According to Business Quant data, Amortizatization of Intangibles over the past three periods registered $14000.0, $9000.0, and $8000.0 for Q4 2023, Q3 2023, and Q2 2023 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Abbott Laboratories 202.72 Bn 197.12 Bn 7.27 Bn -
2 Stryker 126.42 Bn 122.94 Bn 4.50 Bn -
3 Medtronic 119.75 Bn 110.53 Bn 6.41 Bn -
4 Boston Scientific 74.13 Bn 73.60 Bn 3.85 Bn -
5 Edwards Lifesciences 51.78 Bn 47.53 Bn 1.35 Bn 6.60 Mn
6 Dexcom 35.29 Bn 33.34 Bn 830.00 Mn -
7 GE HealthCare Technologies 33.95 Bn 31.85 Bn 2.18 Bn -
8 Koninklijke Philips 26.22 Bn 22.90 Bn 4.55 Bn -
9 Steris 23.21 Bn 22.73 Bn 684.20 Mn -
10 Perspective Therapeutics 396.34 Mn 396.34 Mn - -

Historic Data

Download Data
DateValue
Jun 30, 2024 2,000.00
Jun 30, 2024 2,000.00
Mar 31, 2024 10,000.00
Mar 31, 2024 10,000.00
Dec 31, 2023 14,000.00
Dec 31, 2023 14,000.00
Sep 30, 2023 9,000.00
Sep 30, 2023 9,000.00
Jun 30, 2023 8,000.00
Jun 30, 2023 8,000.00
Mar 31, 2023 9,000.00
Mar 31, 2023 9,000.00
Dec 31, 2022 17,000.00
Dec 31, 2022 17,000.00
Sep 30, 2022 25,000.00
Sep 30, 2022 25,000.00
Jun 30, 2022 16,000.00
Jun 30, 2022 16,000.00
Mar 31, 2022 10,000.00
Mar 31, 2022 10,000.00